Brolucizumab for CNV Associated With Pathologic Myopia

50 participants · First posted Jul 26, 2021

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

60 participants · First posted Oct 24, 2013

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

First posted Oct 11, 2010

Verteporfin(Visudyne)

C₄₁H₄₂N₄O₈ · Rx

Myomir

V myoma

Eyenovia

United States

YSOPIA Bioscience

France

Speech Pathology & Audiology

United States

Alteogen Receives Korean Approval for Aflibercept Biosimilar, Targeting Growing Retinal Disease Market

Alvotech Secures Japanese Approval for Three Biosimilars Including First Global Golimumab Biosimilar

Perioperative Chemoradiation Improves Pathologic Response in Gastric Cancer but Not Survival